Search
for

    GlossaryMedications (Pharmaceuticals)

    substances used to diagnose, treat, or prevent medical conditions

    Medications, also known as drugs or pharmaceuticals, are substances used to diagnose, treat, or prevent diseases and medical conditions. They can be administered in various forms such as pills, injections, or topical applications, and work by interacting with the body's biological systems to achieve their intended effects. For example, minoxidil is a medication commonly used to treat hair loss by stimulating hair follicles to promote growth.

    Related Terms

    Learn

    5 / 10 results

      learn PP405

      mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn Baricitinib

      JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

      learn Mesotherapy

      technique to inject very small amounts of beneficial chemicals into the scalp

      learn Dexpanthenol

      precursor of vitamin B5 with hair stimulating effects

    Research

    5 / 1000+ results

    Community Join

    5 / 579 results

      community Pyrilutamide ,the molecule’s true nature

      by Typical-Promise-3001 in Research  302 upvotes 1 year ago
      Pyrilutamide is a selective AR antagonist with a high binding affinity, making it effective in competing with DHT for androgen receptors. The 1% concentration is more effective than the 0.5%, but the latter may suffice for mild hair loss; the drug is considered a good option for those avoiding 5AR blockers due to side effects.

      community Brief update clascoterone phase 3 - Breezula

      in Research/Science  4 upvotes 1 year ago
      Cosmo Pharmaceuticals has enrolled about 850 out of 1400 patients for their phase 3 clinical trials of clascoterone (Breezula) and claims to be on schedule. The conversation is about hair loss treatments.

      community $120 million Series B funding to Pelsge

      in Research/Science  56 upvotes 5 months ago
      Pelage Pharmaceuticals received $120 million in Series B funding for hair loss treatment development. The conversation expresses excitement and anticipation for the release and effectiveness of the treatment.

      community Approve PP405 quickly you coward

      in Satire  193 upvotes 8 months ago
      Pelage Pharmaceuticals is developing PP405, a topical treatment for hair growth, currently in Phase 2a trials. There is skepticism about the company's claims, and no fast-tracking approval timeline has been detailed.